2010 Metals in Medicine Gordon Research Conference

描述（由申请人提供）：在当地医生的办公室里经常可以看到这样的广告：一个小孩生活在一个寒冷的世界里，上面写着“这个孩子有吸毒问题”，这说明了当今对抗疾病的非常规方法是多么的必要。事实上，戈登研究会议“医学中的金属：药用无机化学”正是这一事业的先锋。在肿瘤领域，顺铂和其他铂类药物已经证明了金属基药物的成功，其他领域仍有希望等待类似的发现。然而，随着许多新方法的出现，研究继续受到过去成功的推动，比如保罗·埃利希的抗梅毒药物阿斯芬那明（沙伐沙）。重要的是，研究人员和临床医生需要一个共享信息和策略的共同论坛。为此目的，必须创造孕育新发现的肥沃环境。医学中的金属戈登研究会议将于2010年6月27日至7月2日在新罕布什尔州的普罗克特学院举行。这次会议将有来自不同背景和不同国籍的不同群体的发言者作广泛的介绍。此外，该组合将包括高级调查员，以及初级调查员和学生演讲。在本次会议上，将首次从提交的摘要中选择相当一部分年轻科学家的演讲，并在实验基础上进行选择，从而为学生和年轻和初级科学家提供一个论坛，以学习和发展开发新疾病治疗的关键技能。我们认为，增加这种新型的介绍对我们的领域很重要，可以帮助促进伙伴关系和合作以及未来药物和治疗方法的发展。这种方法将允许一种格式来更新该领域在临床和实验室疾病斗争中取得成功的格式。在医学中的金属戈登会议上，我们有机会将一群跨学科的科学家和医生聚集在一起，分享和学习无机化学，生物化学，生物学和临床前开发中的医学以及实验或医院类型环境中的患者治疗。在本次会议上，我们将涵盖以下七个健康相关领域：肿瘤学，诊断/成像，核医学，感染性和神经退行性疾病，代谢紊乱，心血管疾病和衰老。

DESCRIPTION (provided by applicant): Advertisements often found in the local physician's office, depicting a small child in a cold world with the text "this child has a drug problem" is documenting how much need there is for unconventional approaches to fight disease today. Indeed, the Gordon Research conference "Metals in Medicine: Medicinal Inorganic Chemistry" is spearheading just this cause. Solidly rooted in the area of oncology where cisplatin and other platinum drugs have documented the success of metal-based drugs, other areas are still hopefully waiting for similar discoveries. However, with many new approaches the search continues fueled by the past successes, such as Paul Ehrlich's anti-syphilitic agent arsphenamine (Salvarsan). Importantly, the researchers and clinicians need a common forum where information and strategies can be shared. To this end the fertile environment upon which discoveries can be born must be created. The Metals in Medicine Gordon Research Conference will be held at Proctor Academy, NH, June 27-July 2nd, 2010. This meeting will feature a broad range of presentations from a diverse group of speakers from different backgrounds and of different Nationalities. In addition, the mix will include senior level investigators, as well as beginning investigators and student presenters. For the first time in this conference a significant fraction of young scientist presentations will be selected from the submitted abstracts and on an experimental basis thus provide a forum for the students and young and beginning scientists to learn and develop key skills to develop new treatments of disease. We believe that the addition of this new type of presentation is important to our area and can help foster partnerships and collaborations and the development of the drug and treatments of tomorrow. Such an approach will allow a format to update those in the area what is successful in the clinic, as well as the laboratory in the battle of diseases. At the Metals in Medicine Gordon Conference we have the opportunity to bring together a group of interdisciplinary scientists and physicians to share and learn from inorganic chemistry, to biochemistry, biology and medicine in preclinical development and to treatment of patients in an experimental or hospital-type setting. At this meeting we will cover the following seven health-related areas: Oncology, Diagnostics/Imaging, Nuclear Medicine, Infectious and Neurodegenerative Diseases, Metabolic Disorders, Cardiovascular Malady, and Aging. PUBLIC HEALTH RELEVANCE: The Gordon Research Conference Metals in Medicine is a multidisciplinary meeting, in which chemists, biochemists, biologist, pharmacist and clinicians come together to learn the state-of-the-art in both basic sciences and clinical work. Metals in Medicine is a rapidly developing field documented with several key drugs, such as cisplatin in oncology, MRI contrast agents, Cardiolyte radiopharmaceutical imaging agents and nanoscience applications. These novel and unconventional approaches to fighting disease require multidisciplinary connectivity to validate the results needed by researchers to develop in laboratories and clinical settings alike. The meeting will feature both current clinical practices and discovery-level research in the following seven health-related areas: Oncology, Diagnostics/Imaging, Nuclear Medicine, Infectious and Neurodegenerative Diseases, Metabolic Disorders, Cardiovascular Malady, and Aging.